TreeWAS – Variant ID: rs11891311

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E80.4 Gilbert's syndrome	1.000	0.000	0.000
E80 Disorders of porphyrin and bilirubin metabolism	0.902	0.098	0.000
E80.6 Other disorders of bilirubin metabolism	0.873	0.127	0.000
E80.7 Disorder of bilirubin metabolism, unspecified	0.716	0.283	0.000
E80.5 Crigler-Najjar syndrome	0.647	0.353	0.000
E80.3 Defects of catalase and peroxydase	0.647	0.353	0.000
E80.0 Hereditary erythropoietic porphyria	0.647	0.353	0.000
E80.1 Porphyria cutanea tarda	0.638	0.361	0.000
E80.2 Other porphyria	0.637	0.362	0.000
E70-E90 Metabolic disorders	0.089	0.911	0.000
E87.5 Hyperkalaemia	0.088	0.912	0.000
E87 Other disorders of fluid, electrolyte and acid-base balance	0.086	0.914	0.000
E87.7 Fluid overload	0.081	0.919	0.000
E88 Other metabolic disorders	0.079	0.921	0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.076	0.924	0.000
E87.0 Hyperosmolality and hypernatraemia	0.071	0.929	0.000
E84 Cystic fibrosis	0.070	0.930	0.000
E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified	0.070	0.930	0.000
E70 Disorders of aromatic amino-acid metabolism	0.068	0.932	0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.064	0.935	0.000
E74 Other disorders of carbohydrate metabolism	0.064	0.935	0.000
E77 Disorders of glycoprotein metabolism	0.064	0.936	0.000
E76 Disorders of glycosaminoglycan metabolism	0.064	0.936	0.000
E72 Other disorders of amino-acid metabolism	0.064	0.936	0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.064	0.936	0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.064	0.936	0.000
E79 Disorders of purine and pyrimidine metabolism	0.062	0.938	0.000
E87.4 Mixed disorder of acid-base balance	0.062	0.938	0.000
E88.3 Tumour lysis syndrome	0.059	0.941	0.000
E85 Amyloidosis	0.059	0.941	0.000
E88.9 Metabolic disorder, unspecified	0.057	0.943	0.000
E88.8 Other specified metabolic disorders	0.056	0.944	0.000
E84.9 Cystic fibrosis, unspecified	0.056	0.944	0.000
L42 Pityriasis rosea	0.056	0.944	0.000
E87.6 Hypokalaemia	0.054	0.946	0.000
E70.3 Albinism	0.052	0.948	0.000
E84.8 Cystic fibrosis with other manifestations	0.050	0.949	0.000
E84.1 Cystic fibrosis with intestinal manifestations	0.050	0.949	0.000
E84.0 Cystic fibrosis with pulmonary manifestations	0.050	0.949	0.000
E70.9 Disorder of aromatic amino-acid metabolism, unspecified	0.049	0.951	0.000
E70.8 Other disorders of aromatic amino-acid metabolism	0.049	0.951	0.000
E70.2 Disorders of tyrosine metabolism	0.049	0.951	0.000
E70.1 Other hyperphenylalaninaemias	0.049	0.951	0.000
E70.0 Classical phenylketonuria	0.049	0.951	0.000
E73 Lactose intolerance	0.048	0.952	0.000
E88.1 Lipodystrophy, not elsewhere classified	0.048	0.952	0.000
E75.2 Other sphingolipidosis	0.047	0.953	0.000
E74.3 Other disorders of intestinal carbohydrate absorption	0.047	0.953	0.000
E75.6 Lipid storage disorder, unspecified	0.046	0.953	0.000
E75.4 Neuronal ceroid lipofuscinosis	0.046	0.953	0.000
E75.3 Sphingolipidosis, unspecified	0.046	0.953	0.000
E75.1 Other gangliosidosis	0.046	0.953	0.000
E75.0 GM2 gangliosidosis	0.046	0.953	0.000
E74.9 Disorder of carbohydrate metabolism, unspecified	0.046	0.953	0.000
E74.8 Other specified disorders of carbohydrate metabolism	0.046	0.953	0.000
E74.4 Disorders of pyruvate metabolism and gluconeogenesis	0.046	0.953	0.000
E74.2 Disorders of galactose metabolism	0.046	0.953	0.000
E74.1 Disorders of fructose metabolism	0.046	0.953	0.000
E74.0 Glycogen storage disease	0.046	0.953	0.000
E71.3 Disorders of fatty-acid metabolism	0.046	0.954	0.000
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified	0.046	0.954	0.000
E71.1 Other disorders of branched-chain amino-acid metabolism	0.046	0.954	0.000
E71.0 Maple-syrup-urine disease	0.046	0.954	0.000
E72.9 Disorder of amino-acid metabolism, unspecified	0.046	0.954	0.000
E72.8 Other specified disorders of amino-acid metabolism	0.046	0.954	0.000
E72.5 Disorders of glycine metabolism	0.046	0.954	0.000
E72.4 Disorders of ornithine metabolism	0.046	0.954	0.000
E72.3 Disorders of lysine and hydroxylysine metabolism	0.046	0.954	0.000
E72.2 Disorders of urea cycle metabolism	0.046	0.954	0.000
E72.1 Disorders of sulphur-bearing amino-acid metabolism	0.046	0.954	0.000
E72.0 Disorders of amino-acid transport	0.046	0.954	0.000
E76.9 Disorder of glucosaminoglycan metabolism, unspecified	0.046	0.954	0.000
E76.8 Other disorders of glucosaminoglycan metabolism	0.046	0.954	0.000
E76.3 Mucopolysaccharidosis, unspecified	0.046	0.954	0.000
E76.2 Other mucopolysaccharidoses	0.046	0.954	0.000
E76.1 Mucopolysaccharidosis, type II	0.046	0.954	0.000
E76.0 Mucopolysaccharidosis, type I	0.046	0.954	0.000
E77.9 Disorder of glycoprotein metabolism, unspecified	0.046	0.954	0.000
E77.8 Other disorders of glycoprotein metabolism	0.046	0.954	0.000
E77.1 Defects in glycoprotein degradation	0.046	0.954	0.000
E77.0 Defects in posttranslational modification of lysosomal enzymes	0.046	0.954	0.000
E75.5 Other lipid storage disorders	0.046	0.954	0.000
E85.3 Secondary systemic amyloidosis	0.045	0.955	0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified	0.045	0.955	0.000
E79.8 Other disorders of purine and pyrimidine metabolism	0.045	0.955	0.000
E79.1 Lesch-Nyhan syndrome	0.045	0.955	0.000
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease	0.043	0.957	0.000
E85.8 Other amyloidosis	0.042	0.958	0.000
E85.2 Heredofamilial amyloidosis, unspecified	0.042	0.958	0.000
E85.1 Neuropathic heredofamilial amyloidosis	0.042	0.958	0.000
E85.0 Nonneuropathic heredofamilial amyloidosis	0.042	0.958	0.000
E88.2 Lipomatosis, not elsewhere classified	0.041	0.959	0.000
E85.9 Amyloidosis, unspecified	0.039	0.961	0.000
E85.4 Organ-limited amyloidosis	0.036	0.964	0.000
E73.8 Other lactose intolerance	0.035	0.965	0.000
E73.1 Secondary lactase deficiency	0.035	0.965	0.000
E73.0 Congenital lactase deficiency	0.035	0.965	0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.028	0.972	0.000
E87.1 Hypo-osmolality and hyponatraemia	0.026	0.974	0.000
A49.8 Other bacterial infections of unspecified site	0.024	0.976	0.000
I38 Endocarditis, valve unspecified	0.000	0.976	0.024
E87.3 Alkalosis	0.023	0.977	0.001
E89.8 Other postprocedural endocrine and metabolic disorders	0.022	0.978	0.000
E89.2 Postprocedural hypoparathyroidism	0.021	0.978	0.000
E89.1 Postprocedural hypoinsulinaemia	0.020	0.979	0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.020	0.980	0.000
E89.5 Postprocedural testicular hypofunction	0.020	0.980	0.000
A49 Bacterial infection of unspecified site	0.020	0.980	0.000
A49.0 Staphylococcal infection, unspecified	0.019	0.981	0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.019	0.981	0.000
E73.9 Lactose intolerance, unspecified	0.018	0.981	0.001
E78.4 Other hyperlipidaemia	0.018	0.982	0.000
A49.1 Streptococcal infection, unspecified	0.018	0.982	0.000
E78 Disorders of lipoprotein metabolism and other lipidaemias	0.017	0.983	0.000
E89.4 Postprocedural ovarian failure	0.015	0.984	0.000
E86 Volume depletion	0.016	0.984	0.000
M10.99 Gout, unspecified (Site unspecified)	0.000	0.985	0.015
A49.3 Mycoplasma infection, unspecified	0.014	0.986	0.000
E89.3 Postprocedural hypopituitarism	0.014	0.986	0.000
E78.1 Pure hyperglyceridaemia	0.014	0.986	0.000
E78.3 Hyperchylomicronaemia	0.013	0.987	0.000
A49.2 Haemophilus influenzae infection, unspecified	0.013	0.987	0.000
M17.0 Primary gonarthrosis, bilateral	0.012	0.988	0.000
R61.9 Hyperhidrosis, unspecified	0.000	0.988	0.012
E78.2 Mixed hyperlipidaemia	0.012	0.988	0.000
E78.6 Lipoprotein deficiency	0.010	0.990	0.000
E83 Disorders of mineral metabolism	0.010	0.990	0.000
M10.9 Gout, unspecified	0.000	0.991	0.009
A49.9 Bacterial infection, unspecified	0.009	0.991	0.000
M10.96 Gout, unspecified (Lower leg)	0.000	0.991	0.009
E78.8 Other disorders of lipoprotein metabolism	0.008	0.992	0.000
E78.9 Disorder of lipoprotein metabolism, unspecified	0.008	0.992	0.000
E87.2 Acidosis	0.008	0.992	0.000
L40-L45 Papulosquamous disorders	0.008	0.992	0.000
M10.92 Gout, unspecified (Upper arm)	0.000	0.992	0.008
H54.9 Unspecified visual impairment (binocular)	0.008	0.992	0.000
O00.1 Tubal pregnancy	0.007	0.992	0.000
M10.90 Gout, unspecified (Multiple sites)	0.000	0.993	0.007
E83.9 Disorder of mineral metabolism, unspecified	0.007	0.993	0.000
E83.8 Other disorders of mineral metabolism	0.007	0.993	0.000
E83.2 Disorders of zinc metabolism	0.007	0.993	0.000
E83.0 Disorders of copper metabolism	0.007	0.993	0.000
F32.0 Mild depressive episode	0.007	0.993	0.000
M10.98 Gout, unspecified (Other)	0.000	0.993	0.007
M10.95 Gout, unspecified (Pelvic region and thigh)	0.000	0.993	0.007
M10.91 Gout, unspecified (Shoulder region)	0.000	0.993	0.007
M17 Gonarthrosis [arthrosis of knee]	0.007	0.993	0.000
Y79.2 Prosthetic and other implants, materials and accessory devices	0.007	0.993	0.000
M17.3 Other posttraumatic gonarthrosis	0.007	0.993	0.000
C50.1 Central portion of breast	0.007	0.993	0.000
M17.1 Other primary gonarthrosis	0.006	0.994	0.000
M10.93 Gout, unspecified (Forearm)	0.000	0.994	0.006
E83.4 Disorders of magnesium metabolism	0.006	0.994	0.000
L44 Other papulosquamous disorders	0.006	0.994	0.000
L41 Parapsoriasis	0.006	0.994	0.000
L45 Papulosquamous disorders in diseases classified elsewhere	0.006	0.994	0.000
M17.2 Posttraumatic gonarthrosis, bilateral	0.006	0.994	0.000
M10.94 Gout, unspecified (Hand)	0.000	0.994	0.006
E83.3 Disorders of phosphorus metabolism	0.006	0.994	0.000
F30-F39 Mood [affective] disorders	0.006	0.994	0.000
F52.2 Failure of genital response	0.005	0.995	0.000
R61 Hyperhidrosis	0.000	0.995	0.005
F52 Sexual dysfunction, not caused by organic disorder or disease	0.005	0.995	0.000
F32 Depressive episode	0.005	0.995	0.000
F34 Persistent mood [affective] disorders	0.005	0.995	0.000
N70.9 Salpingitis and oophoritis, unspecified	0.005	0.995	0.000
M17.5 Other secondary gonarthrosis	0.005	0.995	0.000
N99.3 Prolapse of vaginal vault after hysterectomy	0.005	0.995	0.000
F31 Bipolar affective disorder	0.005	0.995	0.000
O13 Gestational [pregnancy-induced] hypertension without significant proteinuria	0.005	0.995	0.000
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.005	0.995	0.000
F34.1 Dysthymia	0.005	0.995	0.000
F52.0 Lack or loss of sexual desire	0.005	0.995	0.000
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.005	0.995	0.000
E89.0 Postprocedural hypothyroidism	0.005	0.995	0.000
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.005	0.995	0.000
F33 Recurrent depressive disorder	0.005	0.995	0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.005	0.995	0.000
H54.2 Low vision, both eyes	0.005	0.995	0.000
M10 Gout	0.000	0.995	0.005
F50.9 Eating disorder, unspecified	0.005	0.995	0.000
H54.0 Blindness, both eyes	0.005	0.995	0.000
H54 Blindness and low vision	0.005	0.995	0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.005	0.995	0.000
F32.8 Other depressive episodes	0.005	0.995	0.000
F33.9 Recurrent depressive disorder, unspecified	0.005	0.995	0.000
F50 Eating disorders	0.005	0.995	0.000
L41.9 Parapsoriasis, unspecified	0.004	0.995	0.000
L41.8 Other parapsoriasis	0.004	0.995	0.000
L41.5 Retiform parapsoriasis	0.004	0.995	0.000
L41.4 Large plaque parapsoriasis	0.004	0.995	0.000
L41.3 Small plaque parapsoriasis	0.004	0.995	0.000
L41.2 Lymphomatoid papulosis	0.004	0.995	0.000
L41.1 Pityriasis lichenoides chronica	0.004	0.995	0.000
L41.0 Pityriasis lichenoides et varioliformis acuta	0.004	0.995	0.000
L44.9 Papulosquamous disorder, unspecified	0.004	0.995	0.000
L44.8 Other specified papulosquamous disorders	0.004	0.995	0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]	0.004	0.995	0.000
L44.3 Lichen ruber moniliformis	0.004	0.995	0.000
L44.2 Lichen striatus	0.004	0.995	0.000
L44.1 Lichen nitidus	0.004	0.995	0.000
L44.0 Pityriasis rubra pilaris	0.004	0.995	0.000
F39 Unspecified mood [affective] disorder	0.004	0.995	0.000
M17.4 Other secondary gonarthrosis, bilateral	0.004	0.996	0.000
R61.0 Localised hyperhidrosis	0.000	0.996	0.004
L43 Lichen planus	0.004	0.996	0.000
F32.3 Severe depressive episode with psychotic symptoms	0.004	0.996	0.000
S50.9 Superficial injury of forearm, unspecified	0.000	0.996	0.004
E16.2 Hypoglycaemia, unspecified	0.004	0.996	0.000
F38 Other mood [affective] disorders	0.004	0.996	0.000
F51 Nonorganic sleep disorders	0.004	0.996	0.000
M10.07 Idiopathic gout (Ankle and foot)	0.000	0.996	0.004
F33.8 Other recurrent depressive disorders	0.004	0.996	0.000
F34.0 Cyclothymia	0.004	0.996	0.000
B96.3 Haemophilus influenzae [H. influenzae] as the cause of diseases classified to other chapters	0.004	0.996	0.000
R61.1 Generalised hyperhidrosis	0.000	0.996	0.004
F52.9 Unspecified sexual dysfunction, not caused by organic disorder or disease	0.004	0.996	0.000
F52.8 Other sexual dysfunction, not caused by organic disorder or disease	0.004	0.996	0.000
F52.7 Excessive sexual drive	0.004	0.996	0.000
F52.6 Nonorganic dyspareunia	0.004	0.996	0.000
F52.5 Nonorganic vaginismus	0.004	0.996	0.000
F52.4 Premature ejaculation	0.004	0.996	0.000
F52.3 Orgasmic dysfunction	0.004	0.996	0.000
F52.1 Sexual aversion and lack of sexual enjoyment	0.004	0.996	0.000
M10.0 Idiopathic gout	0.000	0.996	0.004
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.004	0.996	0.000
F34.9 Persistent mood [affective] disorder, unspecified	0.004	0.996	0.000
F34.8 Other persistent mood [affective] disorders	0.004	0.996	0.000
F33.0 Recurrent depressive disorder, current episode mild	0.004	0.996	0.000
F30 Manic episode	0.004	0.996	0.000
E16 Other disorders of pancreatic internal secretion	0.004	0.996	0.000
F31.6 Bipolar affective disorder, current episode mixed	0.004	0.996	0.000
Y79 Orthopaedic devices associated with adverse incidents	0.004	0.996	0.000
E21.3 Hyperparathyroidism, unspecified	0.004	0.996	0.000
K80.2 Calculus of gallbladder without cholecystitis	0.004	0.996	0.000
F32.1 Moderate depressive episode	0.004	0.996	0.000
O00 Ectopic pregnancy	0.004	0.996	0.000
F33.4 Recurrent depressive disorder, currently in remission	0.004	0.996	0.000
F50.0 Anorexia nervosa	0.004	0.996	0.000
F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified	0.004	0.996	0.000
F59 Unspecified behavioural syndromes associated with physiological disturbances and physical factors	0.004	0.996	0.000
F55 Abuse of non-dependence-producing substances	0.004	0.996	0.000
F54 Psychological and behavioural factors associated with disorders or diseases classified elsewhere	0.004	0.996	0.000
F51.5 Nightmares	0.004	0.996	0.000
E16.1 Other hypoglycaemia	0.004	0.996	0.000
M10.4 Other secondary gout	0.000	0.996	0.004
M10.2 Drug-induced gout	0.000	0.996	0.004
M10.1 Lead-induced gout	0.000	0.996	0.004
F31.8 Other bipolar affective disorders	0.003	0.996	0.000
F50.8 Other eating disorders	0.003	0.996	0.000
F50.5 Vomiting associated with other psychological disturbances	0.003	0.996	0.000
F50.4 Overeating associated with other psychological disturbances	0.003	0.996	0.000
F50.3 Atypical bulimia nervosa	0.003	0.996	0.000
F50.1 Atypical anorexia nervosa	0.003	0.996	0.000
F51.4 Sleep terrors [night terrors]	0.003	0.996	0.000
H54.3 Unqualified visual loss, both eyes	0.003	0.996	0.000
F30.2 Mania with psychotic symptoms	0.003	0.996	0.000
H54.1 Blindness, one eye, low vision, other eye	0.003	0.996	0.000
R17 Unspecified jaundice	0.004	0.996	0.000
M10.3 Gout due to impairment of renal function	0.000	0.996	0.003
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.003	0.997	0.000
F51.3 Sleepwalking [somnambulism]	0.003	0.997	0.000
A30-A49 Other bacterial diseases	0.003	0.997	0.000
A40.0 Septicaemia due to streptococcus, group A	0.003	0.997	0.000
D75.1 Secondary polycythaemia	0.000	0.997	0.003
L43.3 Subacute (active) lichen planus	0.003	0.997	0.000
L43.2 Lichenoid drug reaction	0.003	0.997	0.000
L43.1 Bullous lichen planus	0.003	0.997	0.000
L43.0 Hypertrophic lichen planus	0.003	0.997	0.000
A40 Streptococcal septicaemia	0.003	0.997	0.000
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.003	0.997	0.000
F38.8 Other specified mood [affective] disorders	0.003	0.997	0.000
F38.1 Other recurrent mood [affective] disorders	0.003	0.997	0.000
F38.0 Other single mood [affective] disorders	0.003	0.997	0.000
F51.9 Nonorganic sleep disorder, unspecified	0.003	0.997	0.000
F51.8 Other nonorganic sleep disorders	0.003	0.997	0.000
F51.2 Nonorganic disorder of the sleep-wake schedule	0.003	0.997	0.000
F51.1 Nonorganic hypersomnia	0.003	0.997	0.000
H54.6 Unqualified visual loss, one eye	0.003	0.997	0.000
K76.0 Fatty (change of) liver, not elsewhere classified	0.003	0.997	0.000
M10.08 Idiopathic gout (Other)	0.000	0.997	0.003
M10.05 Idiopathic gout (Pelvic region and thigh)	0.000	0.997	0.003
M10.04 Idiopathic gout (Hand)	0.000	0.997	0.003
M10.03 Idiopathic gout (Forearm)	0.000	0.997	0.003
M10.02 Idiopathic gout (Upper arm)	0.000	0.997	0.003
M10.01 Idiopathic gout (Shoulder region)	0.000	0.997	0.003
D21.2 Connective and other soft tissue of lower limb, including hip	0.003	0.997	0.000
L43.8 Other lichen planus	0.003	0.997	0.000
A39 Meningococcal infection	0.003	0.997	0.000
F33.1 Recurrent depressive disorder, current episode moderate	0.003	0.997	0.000
O00.9 Ectopic pregnancy, unspecified	0.003	0.997	0.000
F51.0 Nonorganic insomnia	0.003	0.997	0.000
E16.9 Disorder of pancreatic internal secretion, unspecified	0.003	0.997	0.000
E16.8 Other specified disorders of pancreatic internal secretion	0.003	0.997	0.000
E16.4 Abnormal secretion of gastrin	0.003	0.997	0.000
E16.3 Increased secretion of glucagon	0.003	0.997	0.000
F30.8 Other manic episodes	0.003	0.997	0.000
F30.1 Mania without psychotic symptoms	0.003	0.997	0.000
F50.2 Bulimia nervosa	0.003	0.997	0.000
G45.4 Transient global amnesia	0.000	0.997	0.003
H54.5 Low vision, one eye	0.003	0.997	0.000
Y79.8 Miscellaneous devices, not elsewhere classified	0.003	0.997	0.000
Y79.1 Therapeutic (nonsurgical) and rehabilitative devices	0.003	0.997	0.000
Y79.0 Diagnostic and monitoring devices	0.003	0.997	0.000
M10.06 Idiopathic gout (Lower leg)	0.000	0.997	0.003
F31.0 Bipolar affective disorder, current episode hypomanic	0.003	0.997	0.000
F32.2 Severe depressive episode without psychotic symptoms	0.003	0.997	0.000
F00 Dementia in Alzheimer's disease	0.003	0.997	0.000
M10.00 Idiopathic gout (Multiple sites)	0.000	0.997	0.003
A40.3 Septicaemia due to Streptococcus pneumoniae	0.003	0.997	0.000
O00.8 Other ectopic pregnancy	0.003	0.997	0.000
O00.2 Ovarian pregnancy	0.003	0.997	0.000
O00.0 Abdominal pregnancy	0.003	0.997	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.003	0.997	0.000
A39.4 Meningococcaemia, unspecified	0.003	0.997	0.000
E16.0 Drug-induced hypoglycaemia without coma	0.003	0.997	0.000
F05.9 Delirium, unspecified	0.003	0.997	0.000
Q82.8 Other specified congenital malformations of skin	0.000	0.997	0.003
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.003	0.997	0.000
M10.09 Idiopathic gout (Site unspecified)	0.000	0.997	0.003
F53.9 Puerperal mental disorder, unspecified	0.003	0.997	0.000
F53.8 Other mental and behavioural disorders associated with the puerperium, not elsewhere classified	0.003	0.997	0.000
F53.1 Severe mental and behavioural disorders associated with the puerperium, not elsewhere classified	0.003	0.997	0.000
F53.0 Mild mental and behavioural disorders associated with the puerperium, not elsewhere classified	0.003	0.997	0.000
M10.19 Lead-induced gout (Site unspecified)	0.000	0.997	0.003
M10.18 Lead-induced gout (Other)	0.000	0.997	0.003
M10.17 Lead-induced gout (Ankle and foot)	0.000	0.997	0.003
M10.16 Lead-induced gout (Lower leg)	0.000	0.997	0.003
M10.15 Lead-induced gout (Pelvic region and thigh)	0.000	0.997	0.003
M10.14 Lead-induced gout (Hand)	0.000	0.997	0.003
M10.13 Lead-induced gout (Forearm)	0.000	0.997	0.003
M10.12 Lead-induced gout (Upper arm)	0.000	0.997	0.003
M10.11 Lead-induced gout (Shoulder region)	0.000	0.997	0.003
M10.10 Lead-induced gout (Multiple sites)	0.000	0.997	0.003
M10.29 Drug-induced gout (Site unspecified)	0.000	0.997	0.003
M10.28 Drug-induced gout (Other)	0.000	0.997	0.003
M10.27 Drug-induced gout (Ankle and foot)	0.000	0.997	0.003
M10.26 Drug-induced gout (Lower leg)	0.000	0.997	0.003
M10.25 Drug-induced gout (Pelvic region and thigh)	0.000	0.997	0.003
M10.24 Drug-induced gout (Hand)	0.000	0.997	0.003
M10.23 Drug-induced gout (Forearm)	0.000	0.997	0.003
M10.22 Drug-induced gout (Upper arm)	0.000	0.997	0.003
M10.21 Drug-induced gout (Shoulder region)	0.000	0.997	0.003
M10.20 Drug-induced gout (Multiple sites)	0.000	0.997	0.003
M10.49 Other secondary gout (Site unspecified)	0.000	0.997	0.003
M10.48 Other secondary gout (Other)	0.000	0.997	0.003
M10.47 Other secondary gout (Ankle and foot)	0.000	0.997	0.003
M10.46 Other secondary gout (Lower leg)	0.000	0.997	0.003
M10.45 Other secondary gout (Pelvic region and thigh)	0.000	0.997	0.003
M10.44 Other secondary gout (Hand)	0.000	0.997	0.003
M10.43 Other secondary gout (Forearm)	0.000	0.997	0.003
M10.42 Other secondary gout (Upper arm)	0.000	0.997	0.003
M10.41 Other secondary gout (Shoulder region)	0.000	0.997	0.003
M10.40 Other secondary gout (Multiple sites)	0.000	0.997	0.003
F00.9 Dementia in Alzheimer's disease, unspecified	0.003	0.997	0.000
F00.2 Dementia in Alzheimer's disease, atypical or mixed type	0.003	0.997	0.000
F31.7 Bipolar affective disorder, currently in remission	0.003	0.997	0.000
H90.2 Conductive hearing loss, unspecified	0.003	0.997	0.000
Y79.3 Surgical instruments, materials and devices (including sutures)	0.003	0.997	0.000
F30.0 Hypomania	0.003	0.997	0.000
J38.0 Paralysis of vocal cords and larynx	0.003	0.997	0.000
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side	0.003	0.997	0.000
Chapter V Mental and behavioural disorders	0.003	0.997	0.000
F00-F09 Organic, including symptomatic, mental disorders	0.003	0.997	0.000
H54.4 Blindness, one eye	0.003	0.997	0.000
M10.38 Gout due to impairment of renal function (Other)	0.000	0.997	0.003
M10.37 Gout due to impairment of renal function (Ankle and foot)	0.000	0.997	0.003
M10.36 Gout due to impairment of renal function (Lower leg)	0.000	0.997	0.003
M10.35 Gout due to impairment of renal function (Pelvic region and thigh)	0.000	0.997	0.003
M10.34 Gout due to impairment of renal function (Hand)	0.000	0.997	0.003
M10.33 Gout due to impairment of renal function (Forearm)	0.000	0.997	0.003
M10.32 Gout due to impairment of renal function (Upper arm)	0.000	0.997	0.003
M10.31 Gout due to impairment of renal function (Shoulder region)	0.000	0.997	0.003
M10.30 Gout due to impairment of renal function (Multiple sites)	0.000	0.997	0.003
E15 Nondiabetic hypoglycaemic coma	0.003	0.997	0.000
F05 Delirium, not induced by alcohol and other psychoactive substances	0.003	0.997	0.000
A44 Bartonellosis	0.003	0.997	0.000
A43 Nocardiosis	0.003	0.997	0.000
A42 Actinomycosis	0.003	0.997	0.000
A37 Whooping cough	0.003	0.997	0.000
A36 Diphtheria	0.003	0.997	0.000
A32 Listeriosis	0.003	0.997	0.000
A30 Leprosy [Hansen's disease]	0.003	0.997	0.000
A38 Scarlet fever	0.003	0.997	0.000
A35 Other tetanus	0.003	0.997	0.000
A34 Obstetrical tetanus	0.003	0.997	0.000
A33 Tetanus neonatorum	0.003	0.997	0.000
A40.9 Streptococcal septicaemia, unspecified	0.003	0.997	0.000
A40.2 Septicaemia due to streptococcus, group D	0.003	0.997	0.000
E21.2 Other hyperparathyroidism	0.003	0.997	0.000
Z43.1 Attention to gastrostomy	0.003	0.997	0.000
A39.0 Meningococcal meningitis	0.003	0.997	0.000
A40.8 Other streptococcal septicaemia	0.003	0.997	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.003	0.997	0.000
M10.39 Gout due to impairment of renal function (Site unspecified)	0.000	0.997	0.002
F30.9 Manic episode, unspecified	0.002	0.997	0.000
G45.3 Amaurosis fugax	0.000	0.997	0.003
A39.9 Meningococcal infection, unspecified	0.002	0.997	0.000
A39.8 Other meningococcal infections	0.002	0.997	0.000
A39.5 Meningococcal heart disease	0.002	0.997	0.000
A39.3 Chronic meningococcaemia	0.002	0.997	0.000
A39.2 Acute meningococcaemia	0.002	0.997	0.000
A39.1 Waterhouse-Friderichsen syndrome	0.002	0.997	0.000
F80-F89 Disorders of psychological development	0.003	0.997	0.000
E21.4 Other specified disorders of parathyroid gland	0.002	0.997	0.000
M10.97 Gout, unspecified (Ankle and foot)	0.000	0.997	0.002
F00.0 Dementia in Alzheimer's disease with early onset	0.002	0.997	0.000
F45.8 Other somatoform disorders	0.000	0.997	0.002
F80 Specific developmental disorders of speech and language	0.002	0.997	0.000
F00.1 Dementia in Alzheimer's disease with late onset	0.002	0.998	0.000
U80.8 Agent resistant to other penicillin-related antibiotic	0.002	0.998	0.000
F01 Vascular dementia	0.002	0.998	0.000
H52.2 Astigmatism	0.000	0.998	0.002
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.002	0.998	0.000
Z22.5 Carrier of viral hepatitis	0.002	0.998	0.000
A40.1 Septicaemia due to streptococcus, group B	0.002	0.998	0.000
H81.1 Benign paroxysmal vertigo	0.000	0.998	0.002
F70-F79 Mental retardation	0.002	0.998	0.000
F80.1 Expressive language disorder	0.002	0.998	0.000
A31 Infection due to other mycobacteria	0.002	0.998	0.000
S40.0 Contusion of shoulder and upper arm	0.000	0.998	0.002
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.002	0.998	0.000
Z21 Asymptomatic human immunodeficiency virus [HIV] infection status	0.002	0.998	0.000
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.002	0.998	0.000
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances	0.002	0.998	0.000
B44.1 Other pulmonary aspergillosis	0.002	0.998	0.000
F05.0 Delirium not superimposed on dementia, so described	0.002	0.998	0.000
E28.3 Primary ovarian failure	0.002	0.998	0.000
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.002	0.998	0.000
Z08.8 Follow-up examination after other treatment for malignant neoplasm	0.002	0.998	0.000
A30.9 Leprosy, unspecified	0.002	0.998	0.000
A30.8 Other forms of leprosy	0.002	0.998	0.000
A30.5 Lepromatous leprosy	0.002	0.998	0.000
A30.4 Borderline lepromatous leprosy	0.002	0.998	0.000
A30.3 Borderline leprosy	0.002	0.998	0.000
A30.2 Borderline tuberculoid leprosy	0.002	0.998	0.000
A30.1 Tuberculoid leprosy	0.002	0.998	0.000
A30.0 Indeterminate leprosy	0.002	0.998	0.000
A32.9 Listeriosis, unspecified	0.002	0.998	0.000
A32.8 Other forms of listeriosis	0.002	0.998	0.000
A32.7 Listerial septicaemia	0.002	0.998	0.000
A32.1 Listerial meningitis and meningoencephalitis	0.002	0.998	0.000
A32.0 Cutaneous listeriosis	0.002	0.998	0.000
A36.9 Diphtheria, unspecified	0.002	0.998	0.000
A36.8 Other diphtheria	0.002	0.998	0.000
A36.3 Cutaneous diphtheria	0.002	0.998	0.000
A36.2 Laryngeal diphtheria	0.002	0.998	0.000
A36.1 Nasopharyngeal diphtheria	0.002	0.998	0.000
A36.0 Pharyngeal diphtheria	0.002	0.998	0.000
A37.9 Whooping cough, unspecified	0.002	0.998	0.000
A37.8 Whooping cough due to other Bordetella species	0.002	0.998	0.000
A37.1 Whooping cough due to Bordetella parapertussis	0.002	0.998	0.000
A37.0 Whooping cough due to Bordetella pertussis	0.002	0.998	0.000
A42.9 Actinomycosis, unspecified	0.002	0.998	0.000
A42.8 Other forms of actinomycosis	0.002	0.998	0.000
A42.7 Actinomycotic septicaemia	0.002	0.998	0.000
A42.2 Cervicofacial actinomycosis	0.002	0.998	0.000
A42.1 Abdominal actinomycosis	0.002	0.998	0.000
A42.0 Pulmonary actinomycosis	0.002	0.998	0.000
A43.9 Nocardiosis, unspecified	0.002	0.998	0.000
A43.8 Other forms of nocardiosis	0.002	0.998	0.000
A43.1 Cutaneous nocardiosis	0.002	0.998	0.000
A43.0 Pulmonary nocardiosis	0.002	0.998	0.000
A44.9 Bartonellosis, unspecified	0.002	0.998	0.000
A44.8 Other forms of bartonellosis	0.002	0.998	0.000
A44.1 Cutaneous and mucocutaneous bartonellosis	0.002	0.998	0.000
A44.0 Systemic bartonellosis	0.002	0.998	0.000
F01.1 Multi-infarct dementia	0.002	0.998	0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.002	0.998	0.000
F84 Pervasive developmental disorders	0.002	0.998	0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.002	0.998	0.000
E40-E46 Malnutrition	0.002	0.998	0.000
F05.1 Delirium superimposed on dementia	0.002	0.998	0.000
F09 Unspecified organic or symptomatic mental disorder	0.002	0.998	0.000
L40 Psoriasis	0.002	0.998	0.000
F80.2 Receptive language disorder	0.002	0.998	0.000
H90 Conductive and sensorineural hearing loss	0.002	0.998	0.000
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.002	0.998	0.000
Y71 Cardiovascular devices associated with adverse incidents	0.002	0.998	0.000
F89 Unspecified disorder of psychological development	0.002	0.998	0.000
F88 Other disorders of psychological development	0.002	0.998	0.000
F83 Mixed specific developmental disorders	0.002	0.998	0.000
F82 Specific developmental disorder of motor function	0.002	0.998	0.000
F99-F99 Unspecified mental disorder	0.002	0.998	0.000
F06.2 Organic delusional [schizophrenia-like] disorder	0.002	0.998	0.000
F80.9 Developmental disorder of speech and language, unspecified	0.002	0.998	0.000
F80.8 Other developmental disorders of speech and language	0.002	0.998	0.000
F80.3 Acquired aphasia with epilepsy [Landau-Kleffner]	0.002	0.998	0.000
F80.0 Specific speech articulation disorder	0.002	0.998	0.000
L40.8 Other psoriasis	0.002	0.998	0.000
A48 Other bacterial diseases, not elsewhere classified	0.002	0.998	0.000
F02 Dementia in other diseases classified elsewhere	0.002	0.998	0.000
F79 Unspecified mental retardation	0.002	0.998	0.000
Z39.1 Care and examination of lactating mother	0.000	0.998	0.002
F01.8 Other vascular dementia	0.002	0.998	0.000
F01.3 Mixed cortical and subcortical vascular dementia	0.002	0.998	0.000
F01.2 Subcortical vascular dementia	0.002	0.998	0.000
F01.0 Vascular dementia of acute onset	0.002	0.998	0.000
N97.1 Female infertility of tubal origin	0.002	0.998	0.000
Y82 Other and unspecified medical devices associated with adverse incidents	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations